Non-profit · founded 1964

New York Blood Center

New York, United States · nybloodcenter.org

Manage this page

Citations, last 5 years: 3 317
Works, last 5 years: 459
h-index: 290
Scientists listed: 0
Grants since 2016: 125

Grants received

2017–2022 · research · R01

Use of forward Genetic approaches to identify Babesia receptors

Xiuli An · New York Blood Center · funded by National Institutes of Health

$710.1kVector-borne infectious diseases

2017–2018 · research · Global Health

New York Blood Center - to conduct research activities towards the development of a candidate drug against human onchocerciasis

New York Blood Center · funded by Bill and Melinda Gates Foundation

$130k

2017–2020 · research · R21

Innovative 3-D in vitro culturing systems for filarial worms

Sara Lustigman · New York Blood Center · funded by National Institutes of Health

$173.5kParasitic Diseases Research and Treatment

2017–2019 · research · R21

Innovative 3-D in vitro culturing systems for filarial worms

Sara Lustigman · New York Blood Center · funded by National Institutes of Health

$236.3kParasitic Diseases Research and Treatment

2017–2021 · research · R01

Use of forward Genetic approaches to identify Babesia receptors

Xiuli An · New York Blood Center · funded by National Institutes of Health

$719kVector-borne infectious diseases

2017–2021 · research · R01

Use of forward Genetic approaches to identify Babesia receptors

Xiuli An · New York Blood Center · funded by National Institutes of Health

$719kVector-borne infectious diseases

2017–2020 · research · R21

Babesia: Extracellular Vesicles and their Role in Intercellular Communication

Cheryl Ann Lobo · New York Blood Center · funded by National Institutes of Health

$263.4kExtracellular vesicles in disease

2017–2019 · research · R56

Influence of neighborhoods and networks on the HIV care continuum among HIV-infected MSM in NYC

Hong Van Nhu Tieu · New York Blood Center · funded by National Institutes of Health

$817.8kHIV/AIDS Research and Interventions

2017–2021 · research · R01

Use of forward Genetic approaches to identify Babesia receptors

Xiuli An · New York Blood Center · funded by National Institutes of Health

$697.6kVector-borne infectious diseases

2017–2019 · research · R21

Babesia: Extracellular Vesicles and their Role in Intercellular Communication

Cheryl Ann Lobo · New York Blood Center · funded by National Institutes of Health

$219.5kExtracellular vesicles in disease

2016–2019 · research · R56

Functional interplay between Brugia and its Wolbachia symbiont

Elodie Ghedin · New York Blood Center · funded by National Institutes of Health

$770.3kParasitic Diseases Research and Treatment

2016–2018 · research · R21

A novel nanobody with good druggability to prevent and treat MERS-CoV infection

Lanying Du · New York Blood Center · funded by National Institutes of Health

$263.4k

2016–2021 · research · R01

Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization

Karina Yazdanbakhsh · New York Blood Center · funded by National Institutes of Health

$426.5kBlood groups and transfusion

2016–2021 · cooperative agreement · U01

Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination

Shibo Jiang · New York Blood Center · funded by National Institutes of Health

$569.2kSARS-CoV-2 and COVID-19 Research

2016–2021 · cooperative agreement · U01

Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination

Shibo Jiang · New York Blood Center · funded by National Institutes of Health

$595.6kSARS-CoV-2 and COVID-19 Research

2016–2021 · research · R01

Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization

Karina Yazdanbakhsh · New York Blood Center · funded by National Institutes of Health

$426.5kBlood groups and transfusion

2016–2022 · research · R01

Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization

Karina Yazdanbakhsh · New York Blood Center · funded by National Institutes of Health

$426.5kBlood groups and transfusion

2016–2021 · cooperative agreement · U01

Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination

Shibo Jiang · New York Blood Center · funded by National Institutes of Health

$784.5kSARS-CoV-2 and COVID-19 Research

2016–2021 · research · R01

Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization

Karina Yazdanbakhsh · New York Blood Center · funded by National Institutes of Health

$426.5kBlood groups and transfusion

2016–2021 · cooperative agreement · U01

Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination

Lanying Du · New York Blood Center · funded by National Institutes of Health

$526.6kSARS-CoV-2 and COVID-19 Research

2016–2021 · cooperative agreement · U01

Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination

Lanying Du · New York Blood Center · funded by National Institutes of Health

$555.5kSARS-CoV-2 and COVID-19 Research

2016–2018 · research · R21

A novel nanobody with good druggability to prevent and treat MERS-CoV infection

Lanying Du · New York Blood Center · funded by National Institutes of Health

$219.5k

2016–2021 · research · R01

Mechanisms controlling transfusion-associated antibody responses in SCD alloimmunization

Karina Yazdanbakhsh · New York Blood Center · funded by National Institutes of Health

$426.5kBlood groups and transfusion

2015–2020 · research · R01

Immunopathology of ITP

Karina Yazdanbakhsh · New York Blood Center · funded by National Institutes of Health

$493.8kPlatelet Disorders and Treatments

2013–2023 · research · R01

Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120

Asim K Debnath · New York Blood Center · funded by National Institutes of Health

$792.8kHIV Research and Treatment

2013–2023 · research · R01

Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120

Asim K Debnath · New York Blood Center · funded by National Institutes of Health

$792.8kHIV Research and Treatment

2013–2023 · research · R01

Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120

Asim K Debnath · New York Blood Center · funded by National Institutes of Health

$850.9kHIV Research and Treatment

2013–2025 · research · R56

Design of inhibitors targeted to the CD4 binding site on HIV - 1gp120

Asim K Debnath · New York Blood Center · funded by National Institutes of Health

$777.4kHIV Research and Treatment

2013–2023 · research · R01

Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120

Asim K Debnath · New York Blood Center · funded by National Institutes of Health

$812.2kHIV Research and Treatment

2013–2023 · research · R01

Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120

Asim K Debnath · New York Blood Center · funded by National Institutes of Health

$867.1kHIV Research and Treatment

2009–2024 · research · R01

The development of a recombinant vaccine against human onchocerciasis

Sara Lustigman · New York Blood Center · funded by National Institutes of Health

$775.8kParasitic Diseases Research and Treatment

2009–2022 · research · R01

The development of a recombinant vaccine against human onchocerciasis

Sara Lustigman · New York Blood Center · funded by National Institutes of Health

$683.3kParasitic Diseases Research and Treatment

2009–2022 · research · R01

The development of a recombinant vaccine against human onchocerciasis

Sara Lustigman · New York Blood Center · funded by National Institutes of Health

$694.8kParasitic Diseases Research and Treatment

2009–2022 · research · R01

The development of a recombinant vaccine against human onchocerciasis

Sara Lustigman · New York Blood Center · funded by National Institutes of Health

$684.9kParasitic Diseases Research and Treatment

2009–2022 · research · R01

The development of a recombinant vaccine against human onchocerciasis

Sara Lustigman · New York Blood Center · funded by National Institutes of Health

$770.7kParasitic Diseases Research and Treatment

1997–2024 · program · P01

Red Cell Membrane Studies

Mohandas Narla · New York Blood Center · funded by National Institutes of Health

$1.3MErythrocyte Function and Pathophysiology

1997–2022 · program · P01

Red Cell Membrane Studies

Mohandas Narla · New York Blood Center · funded by National Institutes of Health

$1.3MErythrocyte Function and Pathophysiology

1997–2022 · program · P01

Red Cell Membrane Studies

Mohandas Narla · New York Blood Center · funded by National Institutes of Health

$1.3MErythrocyte Function and Pathophysiology

1997–2022 · program · P01

Red Cell Membrane Studies

Mohandas Narla · New York Blood Center · funded by National Institutes of Health

$1.3MErythrocyte Function and Pathophysiology

1997–2022 · program · P01

Red Cell Membrane Studies

Mohandas Narla · New York Blood Center · funded by National Institutes of Health

$1.3M